These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2965928)

  • 1. Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency.
    Bauer KA; Broekmans AW; Bertina RM; Conard J; Horellou MH; Samama MM; Rosenberg RD
    Blood; 1988 May; 71(5):1418-26. PubMed ID: 2965928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.
    Conway EM; Bauer KA; Barzegar S; Rosenberg RD
    J Clin Invest; 1987 Dec; 80(6):1535-44. PubMed ID: 3680513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
    Halbmayer WM; Haushofer A; Toth E
    Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism.
    Kyrle PA; Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Melichart M; Traxler G; Weltermann A; Speiser W; Lechner K
    Thromb Haemost; 1997 May; 77(5):829-33. PubMed ID: 9184387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.
    Bauer KA; Weiss LM; Sparrow D; Vokonas PS; Rosenberg RD
    J Clin Invest; 1987 Dec; 80(6):1527-34. PubMed ID: 2824564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
    Kyrle PA; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Speiser W; Weltermann A; Kaider A; Pabinger I; Lechner K; Eichinger S
    Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation.
    Bauer KA; Rosenberg RD
    Blood; 1987 Aug; 70(2):343-50. PubMed ID: 3607275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred.
    Bovill EG; Bauer KA; Dickerman JD; Callas P; West B
    Blood; 1989 Feb; 73(3):712-7. PubMed ID: 2521802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The genetics of thrombosis].
    Girolami A; Simioni P; Zanardi S; Coser E; Signora S
    Haematologica; 1991 Jun; 76 Suppl 3():249-60. PubMed ID: 1836447
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2.
    Greenberg CS; Hursting MJ; Macik BG; Ortel TL; Kane WH; Moore BM
    Clin Chem; 1994 Oct; 40(10):1962-9. PubMed ID: 7923780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.
    Bauer KA; Goodman TL; Kass BL; Rosenberg RD
    J Clin Invest; 1985 Aug; 76(2):826-36. PubMed ID: 3875633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
    Zöller B; Holm J; Svensson P; Dahlbäck B
    Thromb Haemost; 1996 Feb; 75(2):270-4. PubMed ID: 8815575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased thrombin generation in a child with a combined factor IX and protein C deficiency.
    Negrier C; Berruyer M; Durin A; Philippe N; Dechavanne M
    Blood; 1993 Feb; 81(3):690-5. PubMed ID: 8427961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital antithrombin III deficiency: insights into the pathogenesis of the hypercoagulable state and its management using markers of hemostatic system activation.
    Bauer KA; Rosenberg RD
    Am J Med; 1989 Sep; 87(3B):39S-43S. PubMed ID: 2679069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
    Giannitsis E; Siemens HJ; Mitusch R; Tettenborn I; Wiegand U; Schmücker G; Sheikhzadeh A; Stierle U
    Int J Cardiol; 1999 Mar; 68(3):269-74. PubMed ID: 10213277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease.
    Welters I; Menges T; Ballesteros M; Knothe C; Ruwoldt R; Görlach G; Hempelmann G
    Thromb Res; 1998 Oct; 92(1):1-9. PubMed ID: 9783668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.
    Mormile A; Veglio M; Gruden G; Girotto M; Rossetto P; D'Este P; Cavallo-Perin P
    Acta Diabetol; 1996 Sep; 33(3):241-5. PubMed ID: 8904933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.
    Takahashi H; Wada K; Niwano H; Shibata A
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):813-8. PubMed ID: 1336986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.